French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq.
French drug major Sanofi (SNYNF, SNY) reported Thursday a loss in its fourth quarter, compared to prior year's profit, despite higher net sales. Further, the Board proposed annual dividend of 3.
French drug major Sanofi reported Friday higher profit in its third quarter, while sales declined. Further, the company reiterated fiscal 2023 business earnings view.